Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.141 HKD | -.--% | -4.73% | +25.89% |
Feb. 23 | Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director | CI |
2023 | Aceso Life Science's Loss Widens in Fiscal H1 | MT |
Sales 2022 | 170M 21.74M | Sales 2023 | 207M 26.47M | Capitalization | 1.31B 168M |
---|---|---|---|---|---|
Net income 2022 | -370M -47.32M | Net income 2023 | -264M -33.77M | EV / Sales 2022 | 16.3 x |
Net Debt 2022 | 2.29B 293M | Net Debt 2023 | 2.32B 297M | EV / Sales 2023 | 17.6 x |
P/E ratio 2022 |
-1.15
x | P/E ratio 2023 |
-4.93
x | Employees | 142 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 29.32% |
1 week | -4.73% | ||
1 month | -10.76% | ||
3 months | -6.62% | ||
6 months | -6.00% | ||
Current year | +25.89% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Tak Fok
DFI | Director of Finance/CFO | 48 | 10-12-15 |
Chun Pong Siu
SEC | Corporate Secretary | 44 | 22-08-25 |
Lai Ping Chan
LAW | General Counsel | 40 | 13-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwan Sing Lam
BRD | Director/Board Member | 54 | 12-08-08 |
Ming Sun Chan
BRD | Director/Board Member | 51 | 12-03-28 |
Chi Tak Fok
DFI | Director of Finance/CFO | 48 | 10-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.141 | -.--% | 30,000 |
24-05-30 | 0.141 | -4.73% | 432,000 |
24-05-29 | 0.148 | +6.47% | 918,000 |
24-05-28 | 0.139 | -6.08% | 18,810,000 |
24-05-27 | 0.148 | -.--% | 57,629,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.89% | 133M | |
+6.21% | 10.26B | |
+2.53% | 7.17B | |
+6.24% | 4.24B | |
-19.46% | 1.69B | |
+14.14% | 909M | |
+2.44% | 515M | |
-34.83% | 423M | |
+12.56% | 313M | |
-20.28% | 270M |
- Stock Market
- Equities
- 474 Stock